Bladder cancer updates from the first half of 2026

Zoldonrasib plus daraxonrasib targets KRAS G12D in metastatic pancreatic cancer with promising early results

P-32 microparticle brachytherapy plus FOLFIRINOX shows promising local control in unresectable pancreatic cancer

Therapeutic mammoplasty: An advanced oncoplastic breast surgery technique

Talquetamab plus daratumumab with or without pomalidomide improves PFS in r/r multiple myeloma

Defining breast cancer quality care around the globe

Highlights from APCCC 2026

ASCO 2026: Updates in bladder cancer

ASCO 2026: Updates in renal cancer

Epcoritamab plus rituximab and lenalidomide improves outcomes across follicular lymphoma subgroups

Epcoritamab improves progression-free survival in relapsed or refractory large B-cell lymphoma

Mezigdomide plus carfilzomib dexamethasone improves PFS in R/R multiple myeloma